As expected, control CD117-U937 cells were not affected by CD117×CD3 BTCE (online supplemental figure 6D) and control HEL×CD3 BTCE exhibited no killing against Kasumi-1 and AML-PDX-CD117ASP(816)-VAL cells (figure 6A). This evidence concerns the gene KIT and acute myeloid leukemia.